Boyar Asset Management’s CVS Health CVS Stock Holding History

Boyar Asset Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.13M	Sell	15,758 -1,403	-8%	-$108K	0.64%	42
2025 Q4	$1.36M	Sell	17,161 -634	-4%	-$50K	0.86%	32
2025 Q3	$1.34M	Sell	17,795 -984	-5%	-$67.4K	0.85%	30
2025 Q2	$1.3M	Buy	18,779 +345	+2%	+$22.6K	0.85%	31
2025 Q1	$1.25M	Sell	18,434 -2,239	-11%	-$134K	0.91%	32
2024 Q4	$928K	Sell	20,673 -1,132	-5%	-$63.5K	0.61%	38
2024 Q3	$1.37M	Buy	21,805 +160	+0.7%	+$9.34K	0.88%	31
2024 Q2	$1.28M	Sell	21,645 -115	-0.5%	-$7.19K	0.88%	31
2024 Q1	$1.74M	Sell	21,760 -207	-0.9%	-$15.8K	1.13%	24
2023 Q4	$1.73M	Sell	21,967 -847	-4%	-$60.3K	1.3%	21
2023 Q3	$1.59M	Sell	22,814 -290	-1%	-$20.5K	1.25%	24
2023 Q2	$1.6M	Buy	23,104 +1,152	+5%	+$82K	1.18%	27
2023 Q1	$1.63M	Buy	21,952 +460	+2%	+$38.6K	1.26%	26
2022 Q4	$2M	Sell	21,492 -4,237	-16%	-$409K	1.63%	19
2022 Q3	$2.45M	Buy	25,729 +3,898	+18%	+$386K	2.02%	15
2022 Q2	$2.02M	Sell	21,831 -524	-2%	-$51.1K	1.67%	19
2022 Q1	$2.26M	Sell	22,355 -95	-0.4%	-$9.98K	1.45%	22
2021 Q4	$2.32M	Buy	22,450 +1,112	+5%	+$103K	1.4%	22
2021 Q3	$1.81M	Buy	21,338 +454	+2%	+$38K	1.19%	26
2021 Q2	$1.74M	Buy	20,884 +748	+4%	+$61.3K	1.12%	28
2021 Q1	$1.51M	Buy	20,136 +1,298	+7%	+$94.5K	1.02%	29
2020 Q4	$1.29M	Buy	18,838 +105	+0.6%	+$6.83K	0.97%	32
2020 Q3	$1.09M	Buy	18,733 +786	+4%	+$48.9K	0.92%	31
2020 Q2	$1.17M	Buy	17,947 +2,325	+15%	+$146K	1.08%	28
2020 Q1	$927K	Buy	15,622 +527	+3%	+$35.2K	1.04%	28
2019 Q4	$1.12M	Sell	15,095 -37	-0.2%	-$2.6K	0.81%	37
2019 Q3	$954K	Buy	15,132 +393	+3%	+$23.3K	0.72%	39
2019 Q2	$803K	Buy	14,739 +3,704	+34%	+$199K	0.59%	42
2019 Q1	$595K	Hold	11,035	–	–	0.45%	48
2018 Q4	$723K	Hold	11,035	–	–	0.6%	42
2018 Q3	$869K	Hold	11,035	–	–	0.59%	42
2018 Q2	$710K	Sell	11,035 -40	-0.4%	-$2.64K	0.52%	43
2018 Q1	$689K	Hold	11,075	–	–	0.5%	43
2017 Q4	$803K	Sell	11,075 -340	-3%	-$24.7K	0.57%	42
2017 Q3	$928K	Sell	11,415 -680	-6%	-$53.8K	0.69%	42
2017 Q2	$973K	Hold	12,095	–	–	0.72%	42
2017 Q1	$949K	Buy	12,095 +4,725	+64%	+$377K	0.7%	43
2016 Q4	$582K	Sell	7,370 -4,775	-39%	-$386K	0.58%	48
2016 Q3	$1.08M	Sell	12,145 -50	-0.4%	-$4.72K	0.85%	41
2016 Q2	$1.17M	Sell	12,195 -100	-0.8%	-$9.97K	0.93%	41
2016 Q1	$1.27M	Sell	12,295 -200	-2%	-$19.4K	1%	40
2015 Q4	$1.22M	Hold	12,495	–	–	0.97%	39
2015 Q3	$1.21M	Hold	12,495	–	–	1.03%	37
2015 Q2	$1.31M	Hold	12,495	–	–	1%	39
2015 Q1	$1.29M	Hold	12,495	–	–	0.99%	39
2014 Q4	$1.2M	Hold	12,495	–	–	0.94%	39
2014 Q3	$994K	Hold	12,495	–	–	0.77%	44
2014 Q2	$942K	Hold	12,495	–	–	0.75%	44
2014 Q1	$935K	Hold	12,495	–	–	0.76%	42
2013 Q4	$894K	Hold	12,495	–	–	0.74%	41
2013 Q3	$709K	Sell	12,495 -75	-0.6%	-$4.47K	0.68%	41
2013 Q2	$719K	Buy	+12,570	New	+$728K	0.72%	41

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Boyar Asset Management's CVS Position: Q1 2026 in Review

Boyar Asset Management reduced its CVS Health (CVS) stake by 8.2% in Q1 2026, selling an estimated $108K and leaving 15,758 shares worth $1.13M. The position accounts for 0.64% of the portfolio, ranked #42.

Boyar Asset Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.45M in Q3 2022. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

Boyar Asset Management held 15,758 shares of CVS Health worth $1.13M as of Q1 2026.
Boyar Asset Management sold 1,403 CVS Health shares in Q1 2026, an estimated $108K.
CVS Health made up 0.64% of Boyar Asset Management's portfolio in Q1 2026, its #42 holding.
Boyar Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
Boyar Asset Management's CVS Health position peaked at $2.45M in Q3 2022.
1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Boyar Asset Management's 13F filing for Q1 2026, filed 8 May 2026.